Perrigo (PRGO) Common Equity (2013 - 2026)
Perrigo (PRGO) posted quarterly Common Equity of $2.5 billion for Q1 2026, down 42.74% year-over-year from $4.4 billion in Q1 2025, and down 14.88% quarter-over-quarter from $2.9 billion in Q4 2025.
Perrigo (PRGO) Common Equity (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has reported Common Equity for 14 consecutive years, with $2.5 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Common Equity fell 42.74% year-over-year to $2.5 billion; the TTM figure through Mar 2026 stood at $2.5 billion (down 42.74% YoY), while the FY2025 annual figure was $2.9 billion, down 32.04% from the prior year.
- Common Equity eased to $2.5 billion in Q1 2026 per PRGO's latest filing, from $2.9 billion in the prior quarter.
- Across five years, Common Equity topped out at $5.1 billion in Q2 2022 and bottomed at $2.5 billion in Q1 2026.
- Historically, Common Equity has averaged $4.4 billion across 5 years, with a median of $4.6 billion in 2022.
- Annual changes were most pronounced in 2023 — Common Equity gained 2.94% — and 2026, when it slumped 42.74%.
- Perrigo's Common Equity stood at $4.8 billion in 2022, then declined by 1.53% to $4.8 billion in 2023, then fell by 9.41% to $4.3 billion in 2024, then slumped by 32.04% to $2.9 billion in 2025, then fell by 14.88% to $2.5 billion in 2026.
- Business Quant data shows PRGO's Common Equity at $2.5 billion in Q1 2026, $2.9 billion in Q4 2025, and $4.4 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 22.06 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 7.76 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 3.15 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 47.42 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 6.40 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 14.26 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 3.69 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 6.59 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 4.05 Bn |
| 10 | Perrigo | 1.93 Bn | 1.53 Bn | 313.90 Mn | 2.52 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 27, 2026 | 2.52 Bn |
| Mar 28, 2026 | 2.50 Bn |
| Dec 31, 2025 | 2.94 Bn |
| Sep 27, 2025 | 4.45 Bn |
| Jun 28, 2025 | 4.47 Bn |
| Mar 29, 2025 | 4.36 Bn |
| Dec 31, 2024 | 4.32 Bn |
| Sep 28, 2024 | 4.57 Bn |
| Jun 29, 2024 | 4.55 Bn |
| Mar 30, 2024 | 4.69 Bn |
| Dec 31, 2023 | 4.77 Bn |
| Sep 30, 2023 | 4.74 Bn |
| Jul 1, 2023 | 4.85 Bn |
| Apr 1, 2023 | 4.83 Bn |
| Dec 31, 2022 | 4.84 Bn |
| Oct 1, 2022 | 4.60 Bn |
| Jul 2, 2022 | 4.85 Bn |
| Apr 2, 2022 | 5.10 Bn |
| Dec 31, 2021 | 5.15 Bn |
| Oct 2, 2021 | 5.18 Bn |